Key result
10-dehydrogingerdione and vitamin D3 cut myocardial HFABP expression ~74% in diabetic hyperlipidemic rats.
Why the study?
Hyperlipidemia represents a major risk factor for cardiovascular diseases leading to myocardial injury, prompting investigation into myocardial injury in diabetic hyperlipidemic rats and the effects of vitamin D3 and 10-DHGD.
Does 10-dehydrogingerdione and vitamin D3 improve myocardial injury biomarkers in diabetic hyperlipidemic rats?
Does 10-dehydrogingerdione and vitamin D3 improve myocardial injury biomarkers in diabetic hyperlipidemic rats?
The combination of 10-dehydrogingerdione and vitamin D3 significantly ameliorates myocardial injury, inflammation, and dyslipidemia in a diabetic hyperlipidemic rat model.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for myocardial protection in diabetic hyperlipidemia models; prospective human trials needed before clinical consideration.
Hyperlipidemia represents a major risk factor for cardiovascular diseases leading to myocardial injury. The present study aimed to illustrate the myocardial injury induced in a diabetic hyperlipidemic rat model and the effect of vitamin D3, 10-DHGD intake either individually or in combination form. Male albino rats were selected for the study, received alloxan, hypercholesterolemic diet, and categorized into four groups. The first one (DHC), received hypercholesterolemic diet only and referred to as control. The remaining groups (2, 3, 4) received vitamin D3, 10-DHGD, and combination of both, respectively. Certain biomarkers that were selected for MI evaluation included blood glucose, lipogram pattern, Copeptin, C-reactive protein, myeloperoxidase, heart fatty acid-binding protein, and histopathological changes in myocardium and aorta. Vitamin D3 and 10-DHGD intake induced significant hypoglycemic, hypolipidemic effects, decreased inflammation, and MI biomarkers. Decreased myocardial vacuoles, foam cells, and intimal lesions were also observed compared to DHC. Their combination intake induced more marked reduction in all biomarkers and showed a histopathological pattern similar to normal features of myocardium and aorta. Our findings suggest the therapeutic roles of vitamin D3, 10-DHGD, and their combination against myocardial injury in diabetic hyperlipidemic rats. Impact statement Hyperlipidemia represents a major risk factor for cardiovascular diseases leading to myocardial injury (MI). The present study aimed to illustrate the pattern of myocardial injury induced in diabetic hyperlipidemic rat model and the effect of vitamin D3, 10-dehydrogingerdione (10-DHGD) intake either individually or in combination form.
No takes yet. Share an insight, caveat, or question.
Elseweidy et al. (2020) studied Diabetic hyperlipidemia (n=30). 10-dehydrogingerdione and vitamin D3 vs. Diabetic hyperlipidemic control (no treatment) was evaluated on Myocardial HFABP mRNA expression (p=<0.0001). The combination of 10-dehydrogingerdione and vitamin D3 significantly reduced myocardial HFABP mRNA expression and other injury biomarkers compared to diabetic hyperlipidemic control rats.
Synapse has enriched 10 related papers. Consider them for comparative context: